Jeffrey Farrow
2023 - Tarsus Pharmaceuticals
In 2023, Jeffrey Farrow earned a total compensation of $4M as Chief Financial Officer and Chief Strategy Officer at Tarsus Pharmaceuticals.
Compensation breakdown
Bonus | $100,000 |
---|---|
Non-Equity Incentive Plan | $241,200 |
Option Awards | $1,590,572 |
Salary | $343,751 |
Stock Awards | $1,678,310 |
Other | $37,997 |
Total | $3,991,830 |
Farrow received $1.7M in stock awards, accounting for 42% of the total pay in 2023.
Farrow also received $100K in bonus, $241.2K in non-equity incentive plan, $1.6M in option awards, $343.8K in salary and $38K in other compensation.
Rankings
In 2023, Jeffrey Farrow's compensation ranked 180th out of 2,647 executives tracked by ExecPay. In other words, Farrow earned more than 93.2% of executives.
Classification | Ranking | Percentile |
---|---|---|
All | 180 | 93rd |
Manufacturing | 95 | 93rd |
Chemicals And Allied Products | 62 | 92nd |
Drugs | 61 | 92nd |
Biological Products, Except Diagnostic Substances | 21 | 90th |
Farrow's colleagues
We found three more compensation records of executives who worked with Jeffrey Farrow at Tarsus Pharmaceuticals in 2023.